Novavax developing combination flu, COVID vaccine

US biotech firm Novavax on Monday said it had positive results from preclinical studies of a shot combining its influenza and COVID vaccine candidates.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

The information on this site is of a general nature only and is not intended to address the specific circumstances of any particular individual or entity. It is not intended or implied to be a substitute for professional advice. Read more.